Corrigendum: Ubiquitin Pathway and Ovarian Cancer
Multimed Inc., Milton, ON L9T 2R2, Canada
Curr. Oncol. 2013, 20(3), 280; https://doi.org/10.3747/co.20.1603
Submission received: 10 March 2013
/
Revised: 15 April 2013
/
Accepted: 8 May 2013
/
Published: 1 June 2013
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
The expansion of a gene name was incorrectly given in the paper (p. 326, col. 1, under the subheading “2.6 Ubiquitin-Like Activity of shprh Protein and Ovarian Cancer”).[...]
Share and Cite
MDPI and ACS Style
Current Oncology Editorial Office. Corrigendum: Ubiquitin Pathway and Ovarian Cancer. Curr. Oncol. 2013, 20, 280. https://doi.org/10.3747/co.20.1603
AMA Style
Current Oncology Editorial Office. Corrigendum: Ubiquitin Pathway and Ovarian Cancer. Current Oncology. 2013; 20(3):280. https://doi.org/10.3747/co.20.1603
Chicago/Turabian StyleCurrent Oncology Editorial Office. 2013. "Corrigendum: Ubiquitin Pathway and Ovarian Cancer" Current Oncology 20, no. 3: 280. https://doi.org/10.3747/co.20.1603
